Page last updated: 2024-12-07
pyrroxamycin
Description
pyrroxamycin: isolated from Streptomyces sp. S46506; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
Synonyms (24)
Synonym |
(-)-2,3-dichloro-5-(6,8-dichloro-4h-1,3-benzodioxin-4-yl)-4-nitro-1h-pyrrole |
al-r2081 |
1h-pyrrole, 2,3-dichloro-5-(6,8-dichloro-4h-1,3-benzodioxin-4-yl)-4-nitro-, (-)- |
ll-f42248-alpha |
4,5-dichloro-2-(6',8'-dichloro-4'-h-1,3-benzodioxin-4'-yl)-3-nitropyrrole |
pyrroxamycin |
from streptomyces mg796-af7 |
nsc619798 |
nsc-619798 |
dioxapyrrolomycin |
105888-54-8 |
CHEBI:188711 |
2,3-dichloro-5-[(4s)-6,8-dichloro-4h-1,3-benzodioxin-4-yl]-4-nitro-1h-pyrrole |
2,3-dichloro-5-(6,8-dichloro-4h-1,3-benzodioxin-4-yl)-4-nitro-1h-pyrrole |
unii-v9axn5h81t |
v9axn5h81t , |
2,3-dichloro-5-((4s)-6,8-dichloro-4h-1,3-benzodioxin-4-yl)-4-nitro-1h-pyrrole |
ss-46506a |
1h-pyrrole, 2,3-dichloro-5-((4s)-6,8-dichloro-4h-1,3-benzodioxin-4-yl)-4-nitro- |
antibiotic al-r 2081 |
ll-f 42248.alpha. |
Q27291695 |
DTXSID601140134 |
AKOS040749253 |
Drug Classes (1)
Class | Description |
benzodioxine | Any organic heterobicyclic compound containing ortho-fused benzene and dioxine rings. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |